<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03340532</url>
  </required_header>
  <id_info>
    <org_study_id>17-515</org_study_id>
    <nct_id>NCT03340532</nct_id>
  </id_info>
  <brief_title>HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos</brief_title>
  <official_title>HealthSmart: Promoting Healthy Lifestyles for Young Adult Cancer Survivors Using Educational Videos</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dana-Farber Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the efficacy of the two SunSmart intervention videos to change sun protection&#xD;
      attitudes and behaviors&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SunSmart is a novel video intervention designed to prevent secondary skin cancer in young&#xD;
      adult cancer survivors by increasing their adherence to recommended sun protection.&#xD;
&#xD;
      This study will assess two versions of the SunSmart video intervention. These are: 1) The&#xD;
      INFORMATION VIDEO providing basic information about UV risks, including secondary skin cancer&#xD;
      and the benefits of sun protection (SP), as well as specific SP recommendations and steps to&#xD;
      integrate SP as part of routine self-care for the healthy cancer survivor; and 2) THE&#xD;
      INFORMATION + APPEARANCE VIDEO which will include the full information video, along with an&#xD;
      additional embedded video segment emphasizing negative appearance consequences of UV&#xD;
      exposure. Primary aim of the study is to assess the impact of the video intervention on sun&#xD;
      protection intentions and behavior in young adult cancer survivors compared to a control&#xD;
      intervention. Secondary aims are to describe the impact of the appearance information when&#xD;
      included in the SunSmart intervention, to investigate the extent to which the intervention&#xD;
      changes sun protection through hypothesized mediating variables, and to describe the&#xD;
      consistency of sleep behaviors over time in cancer survivors.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 30, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants are randomized to view one of two SunSmart educational videos or a control video on sleep hygiene. In the three months following the video intervention, participants' sun protection attitudes and behaviors are assessed. An additional measure of sun protection behaviors 12-months later will be provided by participants who participate in the optional 1-year follow-up.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in SP Index scores from baseline to post-summer assessment</measure>
    <time_frame>3 months</time_frame>
    <description>SP index is comprised of 15 self-report items assessing SP Behaviors</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Perceived appearance vulnerability</measure>
    <time_frame>one month</time_frame>
    <description>2 items assessing perceived likelihood that UV exposure will lead to negative appearance changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived health and appearance benefit</measure>
    <time_frame>one month</time_frame>
    <description>8 self-report items assessing expected benefits to SP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Perceived health vulnerability</measure>
    <time_frame>one month</time_frame>
    <description>2 items assessing perceived likelihood that UV exposure will lead to future skin cancers.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SP Intentions</measure>
    <time_frame>one month</time_frame>
    <description>13 items measuring intentions to practice SP</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insomnia symptoms</measure>
    <time_frame>one month</time_frame>
    <description>7 -item Insomnia Severity Scale (ISS). Total ISS scale scores range from a low of 0 (least insomnia) to a high of 28 (worst insomnia)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in SP Index scores from post-summer assessment to one year later</measure>
    <time_frame>12-months</time_frame>
    <description>SP index is comprised of 15 self-report items assessing SP Behaviors</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">266</enrollment>
  <condition>Environmental Exposure to Ultraviolet Light</condition>
  <arm_group>
    <arm_group_label>Sleep hygiene video</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will watch a sleep hygiene video</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information video</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The INFORMATION SunSmart video providing basic information about UV risks, including secondary skin cancer and the benefits of SP, as well as specific SP recommendations and steps to integrate SP as part of routine self-care for the healthy cancer survivor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Information + Appearance video</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>THE INFORMATION + APPEARANCE VIDEO which will include the full information video, along with an additional embedded video segment emphasizing negative appearance consequences of UV exposure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>THE INFORMATION + APPEARANCE VIDEO</intervention_name>
    <description>THE INFORMATION + APPEARANCE VIDEO which will include the full information video, along with an additional embedded video segment emphasizing negative appearance consequences of UV exposure.</description>
    <arm_group_label>Information + Appearance video</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Information SunSmart video</intervention_name>
    <description>The INFORMATION SunSmart video providing basic information about UV risks, including secondary skin cancer and the benefits of SP, as well as specific SP recommendations and steps to integrate SP as part of routine self-care for the healthy cancer survivor</description>
    <arm_group_label>Information video</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sleep hygiene video</intervention_name>
    <description>Contain information on better sleep hygiene</description>
    <arm_group_label>Sleep hygiene video</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  History of cancer diagnosis at least one year prior&#xD;
&#xD;
          -  Current age 18-35&#xD;
&#xD;
          -  No cancer therapy in the prior 3 months (excluding chemoprevention agents)&#xD;
&#xD;
          -  No future cancer therapy planned&#xD;
&#xD;
          -  Able to read and write in English&#xD;
&#xD;
          -  Not compliant with recommended sun protection, as determined by at least one of the&#xD;
             following criteria:&#xD;
&#xD;
               1. Any intentional sunbathing, artificial tanning or a sunburn in the past 5 years;&#xD;
                  OR&#xD;
&#xD;
               2. Having a moderate to light complexion (Fitzpatrick skin types I-IV), and not&#xD;
                  using sunscreen â‰¥ 90% of the time during incidental sun exposure.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of skin cancer diagnosis&#xD;
&#xD;
          -  Enrolled on DFCI protocol 17-385 or any other sun protection intervention in the past&#xD;
             5 years.&#xD;
&#xD;
          -  Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to&#xD;
             complete all measures independently&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christopher Recklitis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dana-Farber Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Dana Farber Cancer Institute</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>November 9, 2017</study_first_submitted>
  <study_first_submitted_qc>November 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>April 19, 2021</last_update_submitted>
  <last_update_submitted_qc>April 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dana-Farber Cancer Institute</investigator_affiliation>
    <investigator_full_name>Christopher Recklitis, Ph.D</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

